$NHHS
NorthStar Healthcare Income, Inc.

2021 Q4 Form 10-Q Financial Statement

#000150370721000043 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $64.41M $67.14M
YoY Change -4.06% -7.74%
Cost Of Revenue $45.78M $46.50M
YoY Change -1.54% 2.52%
Gross Profit $18.63M $20.64M
YoY Change -9.75% -24.72%
Gross Profit Margin 28.92% 30.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.83M $15.95M
YoY Change -13.28% -1.35%
% of Gross Profit 74.22% 77.25%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $15.78M $16.46M
YoY Change -4.13% -4.41%
% of Operating Profit
Other Income/Expense, Net $0.00 $612.0K
YoY Change -100.0%
Pretax Income -$19.64M -$17.10M
YoY Change 14.84% 46.87%
Income Tax $59.00K $15.00K
% Of Pretax Income
Net Earnings -$11.75M -$18.16M
YoY Change -35.27% 24.17%
Net Earnings / Revenue -18.25% -27.04%
Basic Earnings Per Share -$0.06 -$0.09
Diluted Earnings Per Share -$0.06 -$0.09
COMMON SHARES
Basic Shares Outstanding 192.6M shares 191.9M shares 189.8M shares
Diluted Shares Outstanding 191.9M shares 189.8M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $200.5M $89.78M $72.31M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $0.00 $0.00 $21.39M
YoY Change -100.0% -100.0% 0.0%
Intangibles $2.590M
YoY Change
Long-Term Investments $212.3M $220.9M $230.3M
YoY Change -7.36% -4.05% -18.51%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.413B $1.818B $2.008B
YoY Change -26.35% -9.45% -7.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $966.1M $1.428B $1.506B
YoY Change -35.87% -5.16% 1.77%
SHAREHOLDERS EQUITY
Retained Earnings -$1.278B -$1.332B -$1.211B
YoY Change -1.92% 9.97% 19.35%
Common Stock $1.723B $1.720B $1.710B
YoY Change 0.63% 0.59% 0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $444.5M $387.3M $497.9M
YoY Change
Total Liabilities & Shareholders Equity $1.413B $1.818B $2.008B
YoY Change -26.35% -9.45% -7.6%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$11.75M -$18.16M
YoY Change -35.27% 24.17%
Depreciation, Depletion And Amortization $13.83M $15.95M
YoY Change -13.28% -1.35%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001503707
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55190
dei Entity Registrant Name
EntityRegistrantName
NORTHSTAR HEALTHCARE INCOME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3663988
dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
34th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
547-2600
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89777000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65995000 USD
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
192643880 shares
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
20747000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
27575000 USD
CY2021Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
972437000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1483930000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
220936000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
229173000 USD
CY2021Q3 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
0 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
55864000 USD
CY2021Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
488241000 USD
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
5000000 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
6004000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
14735000 USD
CY2021Q3 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
2708000 USD
CY2020Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26483000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
17341000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
9681000 USD
CY2021Q3 us-gaap Assets
Assets
1818191000 USD
CY2020Q4 us-gaap Assets
Assets
1918436000 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
1384765000 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
1416871000 USD
CY2021Q3 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
0 USD
CY2020Q4 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
35000000 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
2897000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8318000 USD
CY2021Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
5609000 USD
CY2020Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3851000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
30918000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
38393000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
3971000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
3941000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1428160000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1506374000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
192406582 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
192406582 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190409341 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190409341 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1923000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1904000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1717915000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1710023000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1331734000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1302755000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-786000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
467000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
387318000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
409639000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
2713000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
2423000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390031000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1818191000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1918436000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
27370000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28006000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83906000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90033000 USD
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
37006000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
39114000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
101669000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
118309000 USD
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
38000 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
23000 USD
us-gaap Other Operating Income
OtherOperatingIncome
80000 USD
us-gaap Other Operating Income
OtherOperatingIncome
165000 USD
CY2021Q3 us-gaap Revenues
Revenues
64414000 USD
CY2020Q3 us-gaap Revenues
Revenues
67143000 USD
us-gaap Revenues
Revenues
185655000 USD
us-gaap Revenues
Revenues
208507000 USD
CY2021Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1067000 USD
CY2020Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1927000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
4667000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
5738000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45784000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46501000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136503000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137530000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
15780000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16459000 USD
us-gaap Interest Expense
InterestExpense
47767000 USD
us-gaap Interest Expense
InterestExpense
49591000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
CY2021Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 USD
CY2020Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8307000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13293000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2432000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3446000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8763000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13828000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15945000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4600000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
85193000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
86782000 USD
us-gaap Costs And Expenses
CostsAndExpenses
251333000 USD
us-gaap Costs And Expenses
CostsAndExpenses
349550000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1447000 USD
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
612000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19637000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17100000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46640000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-133858000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
us-gaap Profit Loss
ProfitLoss
-28906000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-171000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
73000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-951000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11653000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17987000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28979000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169749000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191937161 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191937161 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189756911 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189756911 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191285186 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191285186 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189378629 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189378629 shares
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
us-gaap Profit Loss
ProfitLoss
-28906000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-671000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
459000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1253000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-399000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
459000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1253000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-399000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12424000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17699000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-30159000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-171099000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-100000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-171000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
73000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-951000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12324000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17528000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30232000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-170148000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667504000 USD
CY2020Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
85000 USD
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1998000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1044000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-12547000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
654454000 USD
CY2020Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
39000 USD
CY2020Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
7000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
186000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
517137000 USD
CY2020Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 USD
CY2020Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
75000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
12000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
459000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502047000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 USD
CY2021Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 USD
us-gaap Profit Loss
ProfitLoss
-28906000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
240000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
350000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10155000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403869000 USD
CY2021Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 USD
CY2021Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
146000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 USD
CY2021Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2769000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000 USD
CY2021Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
259000 USD
CY2021Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
45000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-671000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390031000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
222000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2369000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2311000 USD
us-gaap Straight Line Rent
StraightLineRent
-7432000 USD
us-gaap Straight Line Rent
StraightLineRent
-224000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
697000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
92000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1354000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1416000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
142000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
123000 USD
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
194000 USD
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1803000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7769000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7500000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1191000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4363000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7560000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4961000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-5421000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1896000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1758000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1137000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8866000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8274000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
306000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4355000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27980000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
17344000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
8990000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
28078000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
927000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
74376000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
400000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6971000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1963000 USD
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
686000 USD
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
35000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
92367000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6135000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
26000000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
61121000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14418000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
708000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
446000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
457000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
645000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
168000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
428000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
151000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71058000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18144000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16954000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39989000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58820000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110524000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98809000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1391000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
616000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
144000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
112000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
nshi Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale
NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale
488241000 USD
nshi Noncash Or Part Noncash Transaction Reclassification Of Operating Real Estate To Assets Of Held For Sale
NoncashOrPartNoncashTransactionReclassificationOfOperatingRealEstateToAssetsOfHeldForSale
0 USD
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living facilities (“ILF”) and continuing care retirement communities (“CCRC”), which have independent living, assisted living, skilled nursing and memory care available on one campus. Primarily through joint ventures, the Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through its joint ventures also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of September 30, 2021 and December 31, 2020. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of September 30, 2021, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. The Company is sponsored by DigitalBridge Group, Inc. (formerly Colony Capital, Inc.) (NYSE: DBRG) (“DigitalBridge” or the “Sponsor”), a global REIT, that owns, operates and invests across the full spectrum of digital infrastructure and real estate including cell towers, data centers, fiber, small cells and edge infrastructure. Effective June 21, 2021, the Sponsor changed its name from Colony Capital, Inc. to DigitalBridge Group, Inc., and its ticker symbol from “CLNY” to “DBRG.”</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DigitalBridge manages capital on behalf of its stockholders, as well as institutional and retail investors. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of DigitalBridge and manages its day-to-day operations pursuant to an advisory agreement. In September 2021, the Sponsor announced that it had entered into a purchase and sale agreement to divest of its healthcare platform, including the Advisor and the individuals currently engaged in the management and oversight of the healthcare platform.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through September 30, 2021, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The world continues to experience the broad effects of the coronavirus 2019 (“COVID-19”) pandemic. The Company's healthcare real estate business and investments have been challenged by declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. The Company anticipates lasting impacts of the COVID-19 pandemic on its business, even as states and municipalities have eased and may further ease restrictions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuing impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on a variety of factors, which may differ considerably across regions and fluctuate over time. An extended recovery period increases </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, the progression of the global economic recovery from the broad effects of COVID-19 remains difficult for the Company to assess and estimate the future impact of COVID-19 on the Company's results of operations. Accordingly, any estimates of the effects of COVID-19 as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery from COVID-19 and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.</span></div>
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
0 employee
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified on the consolidated statements of operations from other revenue to other income, net to conform to current period presentation. Prior period federal COVID-19 provider relief funds, which totaled $0.6 million and $1.4 million for the three and nine months ended September 30, 2020, respectively, have been reclassified on the consolidated statements of operations from other revenue to other income, net.</span></div>
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
220900000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
400000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q. Such estimates may change and the impact of which could be material.</span></div>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89777000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65995000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
20747000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
27575000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110524000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3500000 USD
nshi Finance Lease Payments
FinanceLeasePayments
500000 USD
nshi Finance Lease Payments
FinanceLeasePayments
500000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
168000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
588000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
167000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
71000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
29000 USD
CY2021Q3 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
50000 USD
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1073000 USD
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
75000 USD
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
998000 USD
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.064
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2021Q3 nshi Number Of Properties Sold
NumberOfPropertiesSold
2 Property
CY2021Q3 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
2673000 USD
CY2020Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
4635000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
0 USD
CY2020Q4 us-gaap Goodwill
Goodwill
21387000 USD
CY2021Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
380000 USD
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
2673000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
26402000 USD
CY2021Q3 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
35000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
81000 USD
CY2021Q3 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
2708000 USD
CY2020Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26483000 USD
CY2021Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
300000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
500000 USD
CY2020Q3 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
1300000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
1400000 USD
CY2021Q3 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
101000 USD
CY2021Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
355000 USD
CY2021Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 USD
CY2021Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 USD
CY2021Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 USD
CY2021Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1241000 USD
CY2021Q3 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
2708000 USD
CY2021Q3 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
6000000 USD
CY2020Q4 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
0 USD
CY2021Q3 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2020Q4 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2021Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
5033000 USD
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3798000 USD
CY2021Q3 us-gaap Incentive To Lessee
IncentiveToLessee
2978000 USD
CY2020Q4 us-gaap Incentive To Lessee
IncentiveToLessee
2246000 USD
CY2021Q3 nshi Utility Deposit Assets
UtilityDepositAssets
406000 USD
CY2020Q4 nshi Utility Deposit Assets
UtilityDepositAssets
447000 USD
CY2021Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
597000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
863000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
17341000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
9681000 USD
CY2021Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2021Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2021Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3500000 USD
CY2020Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2600000 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
10100000 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
10900000 USD
nshi Lessor Concession Granted Period Covid19
LessorConcessionGrantedPeriodCOVID19
P90D
nshi Lessor Concession Granted Repayment Period Covid19
LessorConcessionGrantedRepaymentPeriodCOVID19
P12M
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5400000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91400000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
37800000 USD
CY2021Q3 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
22200000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2019Q1 nshi Equity Method Investment Numberof Facilities Sold
EquityMethodInvestmentNumberofFacilitiesSold
11 facility
CY2019Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
118000000 USD
CY2021Q3 us-gaap Land
Land
121518000 USD
CY2020Q4 us-gaap Land
Land
234706000 USD
CY2021Q3 us-gaap Land Improvements
LandImprovements
17582000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
23797000 USD
CY2021Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
962489000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1389706000 USD
CY2021Q3 us-gaap Tenant Improvements
TenantImprovements
0 USD
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
16172000 USD
CY2021Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4047000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2535000 USD
CY2021Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
82123000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
108055000 USD
CY2021Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1187759000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1774971000 USD
CY2021Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
215322000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
291041000 USD
CY2021Q3 us-gaap Real Estate Investments
RealEstateInvestments
972437000 USD
CY2020Q4 us-gaap Real Estate Investments
RealEstateInvestments
1483930000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
13500000 USD
us-gaap Depreciation
Depreciation
43500000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
15500000 USD
us-gaap Depreciation
Depreciation
47500000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
5400000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
91400000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
220936000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
229173000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
400000 USD
CY2019Q1 nshi Proceeds From Sale Of Property Held For Sale Net
ProceedsFromSaleOfPropertyHeldForSaleNet
4300000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 USD
CY2021Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3942000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
CY2020Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
198000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6971000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1963000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
74400000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
6842000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
478740000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
19696000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20406000 USD
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
670302000 USD
CY2021Q3 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
204276000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1400262000 USD
CY2021Q3 nshi Debt Instrument Principal Deferred Covid19
DebtInstrumentPrincipalDeferredCOVID19
1300000000 USD
CY2021Q3 nshi Debt Instrument Deferred Debt Service Covid19
DebtInstrumentDeferredDebtServiceCOVID19
1300000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8318000 USD
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
15941000 USD
nshi Related Party Transaction Dueto Related Parties Amount Paid
RelatedPartyTransactionDuetoRelatedPartiesAmountPaid
21362000 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
2897000 USD
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
7800000 USD
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
2000000 shares
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
7800000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55625 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45625 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
174458 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
123292 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
278792 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
193250 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
122900000 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2021Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
64414000 USD
CY2021Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1067000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45784000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
15780000 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2021Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2432000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13828000 USD
CY2021Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4600000 USD
CY2021Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7943000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-11753000 USD
CY2020Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
67143000 USD
CY2020Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1927000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46501000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16459000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2020Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3446000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15945000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
612000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
185655000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
4667000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136503000 USD
us-gaap Interest Expense
InterestExpense
47767000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8307000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8544000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44772000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5386000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7479000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
17819000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 USD
us-gaap Profit Loss
ProfitLoss
-28906000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
208507000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
5738000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137530000 USD
us-gaap Interest Expense
InterestExpense
49591000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13293000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8763000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1447000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
CY2021Q3 us-gaap Assets
Assets
1818191000 USD
CY2020Q4 us-gaap Assets
Assets
1918436000 USD
CY2021Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
70 Property
CY2021Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
10118 unit
us-gaap Noninterest Income
NoninterestIncome
185655000 USD
CY2021Q3 nshi Number Of Properties Sold
NumberOfPropertiesSold
2 Property

Files In Submission

Name View Source Status
0001503707-21-000043-index-headers.html Edgar Link pending
0001503707-21-000043-index.html Edgar Link pending
0001503707-21-000043.txt Edgar Link pending
0001503707-21-000043-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20210930.htm Edgar Link pending
nshi-20210930.xsd Edgar Link pending
nshi-20210930_cal.xml Edgar Link unprocessable
nshi-20210930_def.xml Edgar Link unprocessable
nshi-20210930_g1.jpg Edgar Link pending
nshi-20210930_g2.jpg Edgar Link pending
nshi-20210930_htm.xml Edgar Link completed
nshi-20210930_lab.xml Edgar Link unprocessable
nshi-20210930_pre.xml Edgar Link unprocessable
nshi09302021exhibit311.htm Edgar Link pending
nshi09302021exhibit312.htm Edgar Link pending
nshi09302021exhibit321.htm Edgar Link pending
nshi09302021exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending